(Q42073585)

16 October 2017

title

Circadian variation in plasma homovanillic acid level during and after alcohol withdrawal in alcoholic patients (English)

1 reference

16 October 2017

0 references

Sano H

1

1 reference

16 October 2017

Suzuki Y

2

1 reference

16 October 2017

Ohara K

3

1 reference

16 October 2017

Yazaki R

4

1 reference

16 October 2017

Ishigaki T

5

1 reference

16 October 2017

Yokoyama T

6

1 reference

16 October 2017

Ohara K

7

1 reference

16 October 2017

publication date

1 December 1992

1 reference

Alcoholism: Clinical and Experimental Research

16 October 2017

published in

1 reference

16 October 2017

volume

16

1 reference

16 October 2017

issue

6

1 reference

16 October 2017

page(s)

1047-1051

1 reference

NIH conference. Alcohol withdrawal and noradrenergic function

16 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1992.TB00697.X

A comparison of the effects of chronic administration of ethanol and acetaldehyde to mice: evidence for a role of acetaldehyde in ethanol dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1992.TB00697.X

3,4-Dihydroxyphenylacetic acid and homovanillic acid in rat plasma: Possible indicators of central dopaminergic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1992.TB00697.X

Changes in monoamine concentrations in mouse brain associated with ethanol dependence and withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1992.TB00697.X

Acute and chronic effects of neuroleptic drugs on plasma and brain homovanilic acid in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1992.TB00697.X

Influence of dopamine agonists on plasma and brain levels of homovanillic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1992.TB00697.X

Circadian changes in homovanillic acid and ascorbate levels in the rat striatum using microprocessor-controlled voltammetry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1992.TB00697.X

The diurnal variation in plasma homovanillic acid level persists but the variation in 3-methoxy-4-hydroxyphenylglycol level is abolished under constant conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1992.TB00697.X

Circadian variation of plasma homovanillic acid levels is attenuated by fluphenazine in patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1992.TB00697.X

The treatment of alcohol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1992.TB00697.X

Estimation of human blood plasma 5-hydroxyindoleacetic acid and homovanillic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1992.TB00697.X

Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1992.TB00697.X

A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1992.TB00697.X

10.1111/J.1530-0277.1992.TB00697.X

21 January 2018

Identifiers

DOI

1 reference

16 October 2017

1 reference